Dimethyl Sulfoxide
Showing 1 - 25 of 184
Dental Diseases Trial in Cairo (Dimethyl Sulfoxide, 3M ESPE Single bond 2, Filtek Z350 XT, 3 M ESPE, St Paul, MN, USA))
Active, not recruiting
- Dental Diseases
- Dimethyl Sulfoxide
- +3 more
-
Cairo, EgyptFaculty of Dentistry, Cairo University
Oct 22, 2021
Mild to Moderate Anterior Mandibular Segment Crowdind Trial in Latakia (Dihydroxycholecalciferols, dimethyl sulfoxide, serum)
Completed
- Mild to Moderate Anterior Mandibular Segment Crowdind
- Dihydroxycholecalciferols
- +2 more
-
Latakia, Syrian Arab RepublicTishreen University - Faculty of dentistry
Sep 26, 2022
Interstitial Cystitis, Painful Bladder Syndrome Trial (bupivacaine, triamcinolone, and heparin (BTH), dimethyl sulfoxide (DMSO))
Completed
- Interstitial Cystitis
- Painful Bladder Syndrome
- bupivacaine, triamcinolone, and heparin (BTH)
- dimethyl sulfoxide (DMSO)
- (no location specified)
Jan 24, 2022
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Trametinib
Active, not recruiting
- Advanced Lymphoma
- +5 more
- Trametinib Dimethyl Sulfoxide
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Aug 13, 2022
Radiation Dermatitis, Radiation Dermatitis Acute, Breast Cancer Trial in Copenhagen (Melatonin, Dimethyl Sulfoxide, Placebos)
Completed
- Radiation Dermatitis
- +2 more
- Melatonin
- +2 more
-
Copenhagen, Capital Region, DenmarkRigshospitalet
Sep 9, 2021
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in United States (Dabrafenib Mesylate, Tazemetostat
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- Metastatic Melanoma
- Dabrafenib Mesylate
- +2 more
-
Atlanta, Georgia
- +6 more
Nov 30, 2022
BRAF V600E Mutation Trial run by the NHGRI (Dabrafenib Mesylate, Trametinib Dimethyl Sulfoxide)
Completed
- BRAF V600E Mutation
- Dabrafenib Mesylate
- Trametinib Dimethyl Sulfoxide
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 6, 2021
Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial
Active, not recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +4 more
- Dabrafenib Mesylate
- +3 more
-
Philadelphia, PennsylvaniaPerelman Center for Advanced Medicine
Dec 29, 2021
Erdheim-Chester Disease Trial in Houston (Dabrafenib Mesylate, Quality-of-Life Assessment, Questionnaire Administration)
Withdrawn
- Erdheim-Chester Disease
- Dabrafenib Mesylate
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Mar 16, 2021
Low Grade Glioma (LGG) of Brain With BRAF Aberration, High Grade Glioma (HGG) of the Brain With BRAF Aberration, Low Grade
Recruiting
- Low Grade Glioma (LGG) of Brain With BRAF Aberration
- +2 more
- Dabrafenib
- +2 more
-
Phoenix, Arizona
- +12 more
Apr 7, 2022
Melanoma (Skin) Trial in Charlottesville (biological, drug, procedure)
Completed
- Melanoma (Skin)
- incomplete Freund's adjuvant
- +6 more
-
Charlottesville, VirginiaUniversity of Virginia Cancer Center
Mar 26, 2020
Systemic Lupus Erythematosus (SLE) Trial (Blood sample, Urine sample, Saliva sample)
Not yet recruiting
- Systemic Lupus Erythematosus (SLE)
- Blood sample
- +4 more
- (no location specified)
Jul 12, 2022
3TR Systemic Lupus Erythematosus Study Protocol 2
Not yet recruiting
- Systemic Lupus Erythematosus (SLE)
- Blood sample
- +4 more
- (no location specified)
Feb 17, 2023
Lymphoma Trial in Cairo (BEAM Protocol, CEM protocol)
Recruiting
- Lymphoma
- BEAM Protocol
- CEM protocol
-
Cairo, EgyptInternational Medical Center (IMC) Hospital, Cairo, Egypt.
Apr 1, 2023
Wounds and Injuries Trial in Thessaloniki, Mashhad (Platelet-Rich Plasma-Fibrin Glue, Repairing Gel, Repairing Gel and
Recruiting
- Wounds and Injuries
- Platelet-Rich Plasma-Fibrin Glue
- +3 more
-
Thessaloniki, Greece
- +1 more
Aug 1, 2023
Oral Cancer Trial in Cairo (Quercetin 3,3',4',5,6-Pentahydroxyflavone,
Not yet recruiting
- Oral Cancer
- Quercetin 3,3',4',5,6-Pentahydroxyflavone, 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one
- +2 more
-
Cairo, Egypt11 Saraya El Manial
Jul 8, 2022
Osteoarthritis Pain Trial (Etoricoxib 75 mg 4% DMSO Gel, Etoricoxib 75 mg 4% PG Gel, Etoricoxib 150 mg 4% DMSO Gel)
Completed
- Osteoarthritis Pain
- Etoricoxib 75 mg 4% DMSO Gel
- +7 more
- (no location specified)
Feb 7, 2022
Hypersensitivity, Hay Fever, Rhinitis, Allergic, Seasonal Trial (Polvac Grass+Rye)
Not yet recruiting
- Hypersensitivity
- +3 more
- Polvac Grass+Rye
- (no location specified)
Jul 17, 2023
Hypoproliferative Thrombocytopenia Trial in Singapore (Control arm receiving normal (never before frozen) platelets as per
Completed
- Hypoproliferative Thrombocytopenia
- Control arm receiving normal (never before frozen) platelets as per current clinical practice
- Treatment arm receiving cryopreserved platelets
-
Singapore, SingaporeSingapore General Hospital
Sep 23, 2021
Malignant Melanoma, Metastatic, Non Small Cell Lung Cancer Metastatic, Bladder Urothelial Carcinoma, Metastatic Trial in Herlev
Active, not recruiting
- Malignant Melanoma, Metastatic
- +2 more
-
Herlev, Denmark
- +1 more
Jan 10, 2022
Critical Limb Ischemia, Peripheral Arterial Disease Trial in Kuala Lumpur (Stempeucel®)
Not yet recruiting
- Critical Limb Ischemia
- Peripheral Arterial Disease
- Stempeucel®
-
Kuala Lumpur, MalaysiaHospital Canselor Tunku Mukhriz
May 2, 2023
Critical Limb Ischemia, Buerger's Disease Trial in Kuala Lumpur (Adult human bone marrow derived, cultured, pooled, allogeneic
Not yet recruiting
- Critical Limb Ischemia
- Buerger's Disease
- Adult human bone marrow derived, cultured, pooled, allogeneic mesenchymal stromal cells
-
Kuala Lumpur, MalaysiaHospital Canselor Tunku Mukhriz
May 2, 2023